Core Insights - GXO Logistics, Inc. has elected five new members to its Board of Directors, enhancing its leadership team as it aims to become the world's leading logistics provider [1][2] - The company is experiencing growth driven by e-commerce, automation, and outsourcing, positioning itself as the largest pure-play contract logistics provider globally [3] Board of Directors - Todd Cooper, with 25 years of experience in operations, will chair the Compensation Committee [4] - Julio Nemeth, a veteran in consumer goods and supply chain management, will chair the Nominating and Corporate Governance Committee [4] - Torsten Pilz, Ph.D., with extensive experience in supply chain roles at major companies, will chair the Operational Excellence Committee [4] - Laura Wilkin, founder of Excelerate Supply Chain Advisory Services, brings 30 years of experience and will contribute to the board [4] - Kyle Wismans, CFO of XPO, Inc., will chair the Audit Committee, leveraging his financial expertise [4] Company Overview - GXO operates over 1,000 facilities totaling approximately 200 million square feet and employs more than 150,000 team members [3] - The company partners with leading blue-chip companies to address complex logistics challenges using advanced technology and solutions [3]

Part I—Financial Information [Item 1. Financial Statements (Unaudited)](index=3&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) GXO reported a 21% revenue increase to $2.98 billion in Q1 2025, primarily due to the Wincanton acquisition, but recorded a net loss of $95 million, impacted by acquisition-related costs and a significant regulatory expense [Condensed Consolidated Statements of Operations](index=3&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) In Q1 2025, revenue grew to $2.98 billion from $2.46 billion year-over-year, but the operating loss widened to $56 million from $39 million, and the net loss attributable to GXO increased to $96 million, or ($0.81) per share, compared to a net loss of $37 million, or ($0.31) per share, in Q1 2024 Q1 2025 vs Q1 2024 Statement of Operations | (In millions, except per share) | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | **Revenue (in millions)** | $2,977 | $2,456 | | Direct Operating Expense (in millions) | $2,558 | $2,056 | | Operating Loss (in millions) | $(56) | $(39) | | Interest Expense, Net (in millions) | $(32) | $(13) | | Loss Before Income Taxes (in millions) | $(93) | $(46) | | **Net Loss Attributable to GXO (in millions)** | **$(96)** | **$(37)** | | **Diluted Loss Per Share** | **$(0.81)** | **$(0.31)** | [Condensed Consolidated Balance Sheets](index=5&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of March 31, 2025, total assets were $11.32 billion, a slight increase from year-end 2024, with cash and cash equivalents decreasing to $288 million, goodwill increasing to $3.62 billion, total debt rising to $2.72 billion, and total equity decreasing to $2.90 billion Balance Sheet Overview | (In millions) | March 31, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Cash and Cash Equivalents (in millions) | $288 | $413 | | Goodwill (in millions) | $3,623 | $3,549 | | **Total Assets (in millions)** | **$11,322** | **$11,266** | | Total Current Liabilities (in millions) | $3,370 | $3,189 | | Total Long-Term Debt (in millions) | $2,545 | $2,521 | | **Total Liabilities (in millions)** | **$8,418** | **$8,231** | | **Total Equity (in millions)** | **$2,904** | **$3,035** | [Condensed Consolidated Statements of Cash Flows](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) For Q1 2025, net cash provided by operating activities decreased to $29 million from $50 million, while net cash used in investing activities was $77 million, and net cash used in financing activities significantly increased to $66 million due to common stock repurchases Q1 2025 vs Q1 2024 Cash Flow Summary | (In millions) | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Net Cash Provided by Operating Activities (in millions) | $29 | $50 | | Net Cash Used in Investing Activities (in millions) | $(77) | $(82) | | Net Cash Used in Financing Activities (in millions) | $(66) | $(8) | | **Net Decrease in Cash (in millions)** | **$(103)** | **$(45)** | - The primary use of cash in financing activities was **$106 million** for common stock repurchases, partially offset by **$56 million** in net borrowings under revolving credit facilities[20](index=20&type=chunk) [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Key notes detail the Wincanton acquisition for approximately $958 million, adding $707 million in goodwill, with revenue primarily from the United Kingdom and Omnichannel retail, alongside a new $500 million stock repurchase plan and a $66 million expense for an Italian tax investigation Q1 2025 Revenue by Geography | Geography | Revenue (in millions) | | :--- | :--- | | United Kingdom | $1,391 | | United States | $752 | | Netherlands | $232 | | France | $186 | | Other | $416 | | **Total** | **$2,977** | Q1 2025 Revenue by Industry | Industry | Revenue (in millions) | | :--- | :--- | | Omnichannel retail | $1,422 | | Technology and consumer electronics | $393 | | Industrial and manufacturing | $362 | | Food and beverage | $314 | | Consumer packaged goods | $284 | | Other | $202 | | **Total** | **$2,977** | - The company completed the acquisition of Wincanton plc on April 29, 2024, for approximately **£762 million ($958 million)**, resulting in **$707 million** of goodwill, with transaction costs of **$21 million** incurred in Q1 2025[44](index=44&type=chunk)[45](index=45&type=chunk)[46](index=46&type=chunk) - On February 18, 2025, the board authorized a **$500 million** stock repurchase plan, with **2.8 million shares** repurchased for **$111 million** in Q1 2025[74](index=74&type=chunk)[75](index=75&type=chunk) - The company is under investigation by Italian authorities regarding VAT payments, having deposited **€84 million ($91 million)** as restricted cash and accrued a **€61 million ($66 million)** expense for this contingency in Q1 2025[90](index=90&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=25&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management attributes the 21% revenue growth in Q1 2025 primarily to the Wincanton acquisition, which contributed $487 million, while the increased operating loss was driven by higher operating costs, transaction expenses, and a $66 million regulatory charge, maintaining a strong liquidity position with $288 million in cash and $949 million in available borrowing capacity Q1 2025 vs Q1 2024 Results Summary | (In millions) | Q1 2025 | Q1 2024 | $ Change (in millions) | % Change | | :--- | :--- | :--- | :--- | :--- | | Revenue (in millions) | $2,977 | $2,456 | $521 | 21% | | Operating Loss (in millions) | $(56) | $(39) | $(17) | 44% | | Net Loss (in millions) | $(95) | $(36) | $(59) | n/m | - The increase in Q1 2025 revenue was primarily driven by **$487 million** from the Wincanton Acquisition[98](index=98&type=chunk) - A regulatory matter in Italy resulted in a **$66 million** expense in Q1 2025, related to the deductibility of certain VAT payments[104](index=104&type=chunk) - As of March 31, 2025, the company had **$288 million** in cash and cash equivalents and **$949 million** of available borrowing capacity under its revolving credit facilities[110](index=110&type=chunk) - A **$500 million** stock repurchase plan was authorized in February 2025, with approximately **$390 million** remaining authorized as of March 31, 2025[112](index=112&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=31&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reports no material changes to its exposure to market risk for the three months ended March 31, 2025, compared to its 2024 Form 10-K, with key risks remaining related to variable rate debt and foreign currency fluctuations managed with derivative instruments - There have been no material changes to the company's exposure to market risk from those previously disclosed in the Form 10-K for the year ended December 31, 2024[124](index=124&type=chunk) [Controls and Procedures](index=31&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that disclosure controls and procedures were effective as of March 31, 2025, noting the design and implementation of internal controls related to the newly acquired Wincanton plc as a change during the quarter - The CEO and CFO concluded that disclosure controls and procedures were effective as of March 31, 2025[125](index=125&type=chunk) - Changes in internal control over financial reporting included the design and implementation of controls related to the acquisition of Wincanton plc[126](index=126&type=chunk) Part II—Other Information [Legal Proceedings](index=33&type=section&id=Item%201.%20Legal%20Proceedings) The company refers to Note 14 of the financial statements for a detailed description of its legal proceedings, including information on an ongoing Italian VAT investigation - For a description of legal proceedings, the report refers to Note 14, "Commitments and Contingencies" in Part I, Item 1[128](index=128&type=chunk) [Risk Factors](index=33&type=section&id=Item%201A.%20Risk%20Factors) The company states that there are no material changes to the risk factors previously disclosed in its Form 10-K for the year ended December 31, 2024 - There are no material changes to the risk factors as previously disclosed in the Form 10-K for the year ended December 31, 2024[129](index=129&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=33&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) Under its $500 million stock repurchase plan announced in February 2025, the company repurchased approximately 2.77 million shares during the first quarter at an average price of $39.66 per share, with approximately $390 million remaining authorized - On February 18, 2025, the company's board authorized a stock repurchase plan of up to **$500 million**[130](index=130&type=chunk) Q1 2025 Share Repurchase Activity | Period | Total Shares Purchased | Average Price Paid Per Share | Approx. Value Remaining ($M) | | :--- | :--- | :--- | :--- | | Feb 1 - Feb 28 | 481,658 | $40.24 | $480.6 | | Mar 1 - Mar 31 | 2,284,053 | $39.53 | $390.3 | | **Total** | **2,765,711** | **$39.66** | **-** | [Exhibits](index=34&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including a settlement agreement, forms of stock award agreements, CEO and CFO certifications, and Inline XBRL data files - Key exhibits filed include CEO and CFO certifications (Exhibits 31.1, 31.2, 32.1, 32.2) and various compensatory plan agreements[134](index=134&type=chunk)

GXO Logistics (GXO) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Company Participants Malcolm Wilson - CEOBaris Oran - CFOKristine Kubacki - Chief Strategy OfficerJoseph Hafling - VP - Equity ResearchRavi Shankar - ED - Institutional Equity SalesJ. Bruce Chan - DirectorBen Mohr - Transports Equity Research Conference Call Participants Brian Ossenbeck - MD & Senior Analyst - TransportationChris Wetherbee - Senior AnalystBascome Majors - Senior Equity Research AnalystBrandon Oglenski - Director & Senior Equ ...

GXO Logistics (GXO) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Speaker0 Welcome to the GxO First Quarter twenty twenty five Earnings Conference Call and Webcast. My name is Morgan, and I will be your operator for today's call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. Please note that this conference is being recorded. Before the call begins, let me read a brief statement on behalf of the company regarding forward looking statements, ...

GXO Logistics, which belongs to the Zacks Transportation - Air Freight and Cargo industry, posted revenues of $2.98 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 2.24%. This compares to year-ago revenues of $2.46 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on managem ...

May 7, 2025 First quarter 2025 results © GXO Logistics, Inc. Presenters Kristine Kubacki Chief Strategy Officer © GXO Logistics, Inc. 2 Malcolm Wilson Chief Executive Officer 4 Our value creation framework Baris Oran Chief Financial Officer Disclaimer Non-GAAP Financial Measures: As required by the rules of the Securities and Exchange Commission ("SEC"), we provide reconciliations of the non-GAAP financial measures contained in this presentation to the most directly comparable measure under GAAP, which are ...

Increased first quarter revenue 21% year over year, to $3 billion, with organic revenue growth of 3%Grew sales pipeline to three-year high of $2.5 billion, excluding WincantonRepurchased 2.8 million sharesReaffirmed full-year 2025 organic revenue growth and adjusted EBITDA guidance GREENWICH, Conn. , May 07, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced results for the first quarter 2025. Malcolm Wilson, chief executive officer of GXO, said, “GXO delivered a strong first quarter. ...

"We signed $228 million of new business wins and our sales pipeline of $2.5 billion, excluding Wincanton, stands at its highest level in three years. We've finalized a landmark deal with England's National Health Service Supply Chain. This is our largest-ever contract and carries a total lifetime value of about $2.5 billion. "To date, we've secured over $700 million of incremental revenue for 2025, and have an additional $300 million already won for 2026. In a dynamic trade environment, customers need a rel ...

Core Insights - GXO Logistics has secured a landmark 10-year, $2.5 billion contract with the UK's National Health Service (NHS), significantly expanding its presence in healthcare logistics [1][2] - The company aims to leverage this agreement as a springboard for further growth in the healthcare sector across the U.K., U.S., and Europe [2] - GXO's logistics solutions are tailored to meet the complex needs of healthcare logistics, including critical fulfillment and inventory management for hospital supplies and medical devices [3] Company Overview - GXO Logistics is the world's largest pure-play contract logistics provider, benefiting from the rapid growth of e-commerce, automation, and outsourcing [4] - The company operates over 1,000 facilities totaling approximately 200 million square feet and employs more than 150,000 team members [4] - GXO partners with leading blue-chip companies to address complex logistics challenges using technologically advanced supply chain solutions [4] Strategic Initiatives - GXO will manage 8 NHS Supply Chain distribution centers and a dedicated fleet of over 300 vehicles to provide modern logistics solutions [2] - The company has also initiated a multi-year agreement with Siemens Healthineers in the U.S. to expand its Forward Stocking Network, including new 'Mega Depots' [2] - GXO has signed additional agreements with large healthcare brands in Europe, further enhancing its healthcare logistics footprint [2] Operational Focus - GXO's logistics solutions ensure full visibility of inventory and orders while managing hundreds of thousands of sensitive, high-value SKUs [3] - The company emphasizes time-sensitive and emergency deliveries, process standardization, data accuracy, and regulatory compliance to enhance patient care [3]

Wall Street expects a year-over-year decline in earnings on higher revenues when GXO Logistics (GXO) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 7, 2025, might help the stock move higher if these key numbers are better than expectat ...